Project information
Genomic Data Infrastructure
(GDI)
- Project Identification
- 101081813
- Project Period
- 11/2022 - 10/2026
- Investor / Pogramme / Project type
-
European Union
- DIGITAL EUROPE
- MU Faculty or unit
- Institute of Computer Science
- Other MU Faculty/Unit
-
Central European Institute of Technology
- prof. RNDr. Šárka Pospíšilová, Ph.D.
- Mgr. Vojtěch Bystrý, Ph.D.
- Dr.-Ing. Josef Horák
- Mgr. Jakub Hynšt, Ph.D.
- Mgr. Daniela Komrsková, Ph.D.
- Mgr. Patricie Skaláková
- Ing. Jan Svatoň, MSc.
- Cooperating Organization
-
University of Ljubljana
German Cancer Research Center
University of Helsinki
Tartu Ülikool
University of Oslo
Universität Tübingen
Universita Cattolica di Milano
Uppsala universitet
Royal College of Surgeons in Ireland
Institut national de la santé et de la recherche médicale
Foundation Centre for Genomic Regulation
University Hospital Groningen
Erasmus University Medical Center Rotterdam
University of Luxembourg
VIB
Carlos III Health Institute
EMBL ¨(EUROPEAN MOLECULAR BIOLOGY LABORATORY)
- Responsible person Dr. Serena Scollen
MEDICAL UNIVERSITY SOFIA
The Netherlands Cancer Institute
The Genomic Data Infrastructure (GDI) project brings together national agencies, research organisations, and technology providers in 22 countries to provide a cross-border federated network of national genome collections, associated with other relevant data, for advancing data-driven biomedical research and personalised medicine solutions to benefit citizens of Europe. The project is designed to support the European 1+ Million Genomes (1+MG) Initiative. Specifically, GDI will drive the development, deployment and operation of sustainable data-access infrastructures within each participating country including the legal frameworks, operational procedures and ethics principles
required to foster and maintain citizens' trust in cross-border access to highly sensitive personal data. It will unlock a data network of over 1 million genome sequences for research and clinical reference creating unprecedented opportunities for routine transnational, multi-stakeholder actions in personalised medicine for common, rare and infectious diseases. Authorised data users, such as clinicians, researchers and innovators, will be able to advance our understanding of genomics for more precise and faster clinical decision-making, diagnostics, treatments and predictive medicine, and for improved public health measures that will benefit citizens, healthcare systems
and the overall economy. Thus, GDI is one critical component of Europe's ambition to lead the integration of genomics into healthcare and the GDI project is designed to interact with the other actors working towards this ambition via incremental milestones that drive alignment along a dynamic roadmap.
Sustainable Development Goals
Masaryk University is committed to the UN Sustainable Development Goals, which aim to improve the conditions and quality of life on our planet by 2030.